STXS : Summary for STEREOTAXIS INC COM USD0.001 - Yahoo Finance

U.S. Markets open in 9 hrs 19 mins

Stereotaxis, Inc. (STXS)


NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
0.62-0.00 (-0.81%)
At close: 3:25PM EST
People also watch
HNSNSPNCNUROSTAAROSG
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close0.62
Open0.62
Bid0.93 x 1300
Ask0.95 x 1000
Day's Range0.61 - 0.63
52 Week Range0.47 - 1.95
Volume87,947
Avg. Volume50,186
Market Cap13.47M
Beta1.98
PE Ratio (TTM)-0.71
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • GlobeNewswire4 days ago

    First Site in Japan to Install Stereotaxis Technology Completes 250 Procedures

    LOUIS, Feb. 23, 2017-- Stereotaxis, Inc., a global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that Takatsuki General Hospital, a leading acute care ...

  • GlobeNewswire11 days ago

    Montreal Heart Institute Implements Stereotaxis Technologies

    LOUIS, Feb. 16, 2017-- Stereotaxis, Inc., a global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, and the Montreal Heart Institute, an internationally recognized research ...

  • American City Business Journals20 days ago

    Cortex-based medical device maker's CEO resigns

    William C. Mills III has resigned as CEO of Stereotaxis, the St. Louis-based medical device maker that operates out of the Cortex innovation district. Mills also resigned his board seat at the company, which develops medical devices for treating cardiac arrhythmias. David Fischel has been named acting CEO and chairman of the board, effective immediately.